Evolus price target raised to $20 from $16 at Barclays

Barclays analyst Balaji Prasad raised the firm’s price target on Evolus to $20 from $16 and keeps an Overweight rating on the shares. The company’s long-term outlook was well received with stock up 8%, primarily in the operating margin guide of at least 20% by 2028, the analyst tells investors in a research note.